Salarius Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Salarius Pharmaceuticals has a total shareholder equity of $2.9M and total debt of $328.8K, which brings its debt-to-equity ratio to 11.2%. Its total assets and total liabilities are $3.9M and $934.6K respectively.
Key information
11.2%
Debt to equity ratio
US$328.85k
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.28m |
| Equity | US$2.92m |
| Total liabilities | US$934.58k |
| Total assets | US$3.86m |
Recent financial health updates
Recent updates
Salarius pharmaceuticals announces 1-for-25 reverse stock split
Oct 14Salarius adds 12% after updates on clinical programs and financials
Sep 13Salarius Pharma adds two Mayo Clinic sites to phase 1/2 trial of Seclidemstat as treatment for cancers
Aug 22Salarius Pharmaceuticals GAAP EPS of -$0.09 beats by $0.01
Aug 08Salarius Pharmaceuticals and VolitionRx enter into R&D collaboration agreement
Aug 02Salarius Pharma reports new seclidemstat results in Ewing sarcoma and other solid tumors at ASCO21
Jun 07Salarius Pharmaceuticals (SLRX) Investor Presentation - Slideshow
May 27Salarius Pharmaceuticals (NASDAQ:SLRX) Shareholders Have Enjoyed An Impressive 155% Share Price Gain
Feb 09
Salarius Pharmaceuticals receives second installment of $1.7M in payments
Jan 13Salarius Pharma raises $3.5M via warrant exercise
Dec 11Salarius Pharmaceuticals EPS in-line, beats on revenue
Nov 11Financial Position Analysis
Short Term Liabilities: SLRX's short term assets ($3.8M) exceed its short term liabilities ($934.6K).
Long Term Liabilities: SLRX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: SLRX has more cash than its total debt.
Reducing Debt: SLRX's debt to equity ratio has increased from 7.7% to 11.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SLRX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SLRX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 19.9% each year